IPSC vs LYB · rev $6.6M vs P/E 21, rev $40.30B
Century Therapeutics Inc (IPSC) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported LYB revenue for 2024-12-31 was $40.30B. Net income was $1.37B. Revenue was down 2.0% from 2023-12-31 to 2024-12-31. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
IPSC currently screens at market cap $47.8M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the IPSC and LYB stock pages for the full models.
Not investment advice.